SLU Medical Students Show Off Research
Saint Louis University's School of Medicine held its 47th annual Alpha Omega Alpha (AOA) Medical Student Research Forum, showcasing medical students' research and honoring the top contributions.
Earlier in January, 36 medical students presented posters on their research, and on Jan. 25, six finalists gave oral presentations.
Andrew Melson and Joseph Rutledge were awarded first place prizes of $250 each. Melson conducted his research in the laboratory of Richard Griffey, M.D., at Washington University. Rutledge was mentored by Michael Anne Gratton, Ph.D., SLU professor of otolaryngology, in collaboration with Michael Rauchman, M.D., associate professor in the department of internal medicine. Both Melson and Rutledge will be sent to the 53rd Annual National Student Research Forum in Galveston, Texas on April 26-27, where they will present their research and compete with students from all over the country for additional prizes.
Mike Carl and Konstantin Malley were awarded third place prizes of $150 each. Devin West and John Vu received honorable mentions and $75 each.
The research forum is an annual event sponsored by Saint Louis University School of Medicine. All SLU medical students can participate, but they may only present research that they have done while in medical school.
Carmine Coscia, Ph.D., professor of biochemistry and molecular biology, is the faculty coordinator of the AOA Student Research Forum. Serving as judges along with Coscia were Michael Green, Ph.D., professor of molecular microbiology and immunology; Paul Hauptman, M.D., professor of cardiology; Mark Voigt, Ph.D., professor of pharmacological and physiological science; and Michael Rauchman.
Established in 1836, Saint Louis University School of Medicine has the distinction of awarding the first medical degree west of the Mississippi River. The school educates physicians and biomedical scientists, conducts medical research, and provides health care on a local, national and international level. Research at the school seeks new cures and treatments in five key areas: cancer, infectious diseases, liver disease, aging and brain diseases and heart/lung disease.